BPHL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.531600E-01
Normal-vs-Stage2
5.981200E-01
Normal-vs-Stage3
3.066000E-01
Normal-vs-Stage4
8.033600E-01
Stage1-vs-Stage2
1.377030E-01
Stage1-vs-Stage3
2.307800E-01
Stage1-vs-Stage4
6.892200E-01
Stage2-vs-Stage3
3.288200E-01
Stage2-vs-Stage4
3.792500E-02
Stage3-vs-Stage4
1.528790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.471400E-01
Normal-vs-AfricanAmerican
8.030200E-01
Normal-vs-Asian
1.343770E-01
Caucasian-vs-AfricanAmerican
4.543000E-01
Caucasian-vs-Asian
7.657900E-02
AfricanAmerican-vs-Asian
9.327500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.623600E-01
Normal-vs-Female
4.041200E-01
Male-vs-Female
5.375400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.707600E-01
Normal-vs-Age(41-60Yrs)
3.715200E-01
Normal-vs-Age(61-80Yrs)
2.715600E-01
Normal-vs-Age(81-100Yrs)
9.772000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.028790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.981580E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.956000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.660400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.003980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.773900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.362400E-01
Normal-vs-Daily Drinker
5.674600E-01
Normal-vs-Weekly Drinker
3.003400E-01
Normal-vs-Occasional Drinker
8.181200E-01
Normal-vs-Social Drinker
5.132400E-01
Non Drinker-vs-Daily Drinker
3.285000E-01
Non Drinker-vs-Weekly Drinker
4.753600E-01
Non Drinker-vs-Occasional Drinker
5.034400E-01
Non Drinker-vs-Social Drinker
9.669800E-01
Daily Drinker-vs-Weekly Drinker
9.721400E-01
Daily Drinker-vs-Occasional Drinker
1.664560E-01
Daily Drinker-vs-Social Drinker
3.078800E-01
Weekly Drinker-vs-Occasional Drinker
2.416400E-01
Weekly Drinker-vs-Social Drinker
4.227400E-01
Occasional Drinker-vs-Social Drinker
5.698000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.253630E-01
Normal-vs-Grade 2
2.416000E-02
Normal-vs-Grade 3
1.167710E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.535200E-01
Grade 1-vs-Grade 3
2.760000E-01
Grade 1-vs-Grade 4
1.253630E-01
Grade 2-vs-Grade 3
8.556400E-02
Grade 2-vs-Grade 4
2.416000E-02
Grade 3-vs-Grade 4
1.167710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.471800E-01
Normal-vs-NonDiabetic
3.524400E-01
Diabetic-vs-NonDiabetic
4.728400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.722000E-01
Normal-vs-NoPancreatitis
3.310800E-01
Pancreatitis-vs-NoPancreatitis
6.276400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.772600E-01
Normal-vs-N1
2.527800E-01
N0-vs-N1
2.066600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.606200E-01
Normal-vs-TP53-NonMutant
4.533400E-01
TP53-Mutant-vs-TP53-NonMutant
8.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
